Zai Lab (ZLAB) Treasury Shares (2021 - 2026)
Zai Lab (ZLAB) posted Treasury Shares of $31.3 million for Q1 2026, up 7.81% sequentially from $29.1 million in Q4 2025, and up 50.32% YoY from $20.8 million in Q1 2025.
Analysis
Zai Lab (ZLAB) Treasury Shares (2021 - 2026) Analysis & Trends
Zai Lab has reported Treasury Shares for 6 years, with the latest figure at $31.3 million in Q1 2026.
- Quarterly Treasury Shares rose 50.32% year-over-year to $31.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.3 million (up 50.32% YoY) and the FY2025 annual result came in at $29.1 million, up 39.44% from the prior year.
- Treasury Shares improved to $31.3 million in Q1 2026 per ZLAB's latest filing, from $29.1 million in the prior quarter.
- Over five years, Treasury Shares peaked at $8.6 million in Q1 2026 and troughed at $398080.0 in Q1 2022.
- A 4-year average of $4.6 million and a median of $4.9 million in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2024: Treasury Shares surged 1104.44% in 2022, then changed 0.0% in 2024.
- Over 5 years, Treasury Shares stood at $11.9 million in 2022, then jumped by 75.74% to $20.8 million in 2023, then changed by 0.0% to $20.8 million in 2024, then surged by 39.44% to $29.1 million in 2025, then advanced by 7.81% to $31.3 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $31.3 million, $29.1 million, and $29.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | Zai Lab | 2.93 Bn | 2.22 Bn | 58.15 Mn | 9.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.52 Mn |
| Jun 30, 2026 | 9.78 Mn |
| Jun 30, 2026 | 33.52 Mn |
| Jun 30, 2026 | 9.78 Mn |
| Mar 31, 2026 | 8.60 Mn |
| Mar 31, 2026 | 31.32 Mn |
| Mar 31, 2026 | 31.32 Mn |
| Mar 31, 2026 | 8.60 Mn |
| Dec 31, 2025 | 7.43 Mn |
| Dec 31, 2025 | 7.43 Mn |
| Dec 31, 2025 | 29.05 Mn |
| Dec 31, 2025 | 29.05 Mn |
| Sep 30, 2025 | 7.43 Mn |
| Sep 30, 2025 | 7.43 Mn |
| Sep 30, 2025 | 29.05 Mn |
| Sep 30, 2025 | 29.05 Mn |
| Jun 30, 2025 | 20.86 Mn |
| Jun 30, 2025 | 4.92 Mn |
| Jun 30, 2025 | 20.86 Mn |
| Jun 30, 2025 | 4.92 Mn |